(Reuters) - The European drugs regulator said on Friday it was reviewing anti hair-loss drugs, including Organon's Propecia and its generic versions, over the risks of suicidal thoughts.
The European Medicines Agency said it would recommend whether the marketing authorisations for the drugs should be withdrawn, suspended or maintained across the region following its review.
Oral anti-baldness drugs called finasteride and dutasteride have a known risk of psychiatric side effects. Finasteride, branded as Propecia, already comes with warnings about the risk of suicidal thoughts.
(로이터) - 유럽 의약품 규제 당국은 금요일에 ㅈㅅ충동의 위험성에 대해 오가논의 프로페시아 및 그 제네릭 버전을 포함한 탈모 방지 약물을 검토하고 있다고 밝혔다.
복용할까하는데 부작용때문에 고민이네요
☞ 본 게시판에서 모발이식 수술 후기는 신고 바랍니다. (삭제 및 탈퇴)
댓글 5